San Diego, CA, United States of America

Jeffrey Miner

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: A Spotlight on Inventor Jeffrey Miner

Introduction

Jeffrey Miner, based in San Diego, California, is a distinguished inventor with a remarkable portfolio of five patents. His contributions in the field of pharmaceuticals, particularly in the treatment of crystal arthropathy disorders, showcase his innovative spirit and commitment to improving healthcare outcomes.

Latest Patents

Miner's latest inventions include several notable patents for CXCR-2 inhibitors that are instrumental in the treatment and prevention of gout. One of these patents describes the compound N-(2-((2,3-difluorobenzyl)thio)-6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)pyrimidin-4-yl)azetidine-1-sulfonamide (compound 3). This compound, along with another patent for N-(6-(((2R,3S)-3,4-dihydroxy butan-2-yl)oxy)-2-((4-fluorobenzyl)thio)pyrimidin-4-yl)-3-methyl-azetidine-1-sulfonamide (compound 4), acts as a chemokine modulator, proving beneficial in conditions requiring modulation of chemokine receptor activity. Additionally, his research describes the use of Sodium 2-(5-bromo-4-(4-cyclopropyl-naphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate for the effective treatment of gout.

Career Highlights

Jeffrey Miner works for Ardea Biosciences, Inc., a biotechnology company recognized for its innovative approach to treating diseases through the development of novel pharmaceuticals. Over the years, Miner’s contributions have significantly enhanced the company's research capabilities and broadened its therapeutic offerings.

Collaborations

Throughout his career, Miner has collaborated with esteemed colleagues such as Barry D Quart and Jean-Luc Girardet. These partnerships have not only enriched his research but have also contributed to advancements in the fields of pharmacology and therapeutic development.

Conclusion

In summary, Jeffrey Miner stands out as an influential inventor whose work is paving the way for new treatments in the management of gout and similar disorders. His ongoing research, innovative patents, and robust collaborations at Ardea Biosciences, Inc. continue to inspire future breakthroughs in medicine and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…